Literature DB >> 30037737

Incidence, Predictors, and Outcomes of Colonic Ischaemia in Abdominal Aortic Aneurysm Repair.

Christian-Alexander Behrendt1, Henrik C Rieß2, Thea Schwaneberg2, Axel Larena-Avellaneda2, Tilo Kölbel2, Nikolaos Tsilimparis2, Kostas Spanos2, Eike S Debus2, Art Sedrakyan3.   

Abstract

OBJECTIVE/
BACKGROUND: Colonic ischaemia (CI) is a severe complication following abdominal aortic aneurysm (AAA) repair, leading to high morbidity and mortality. The aim of the study was to determine the incidence, predictors, and outcomes of CI following AAA repair.
METHODS: National claims from Germany's third largest insurance provider, DAK-Gesundheit, were used to investigate CI after intact (iAAA) and ruptured (rAAA) AAA repairs. Patients undergoing endovascular (EVAR) or open surgical (OSR) repairs between January 2008 and December 2017 were included in the study.
RESULTS: There were 9145 patients (8248 iAAA and 897 rAAA) undergoing EVAR or OSR procedures and the median follow up was 2.28 years. Most patients were male (79.2% iAAA, 79.3% rAAA); the median age was 73.0 years (iAAA group) and 76.0 years (rAAA group). Overall, CI occurred 97 (1.2%) times after iAAA and 95 (10.6%) after rAAA. In univariable analyses CI occurred less often after EVAR than after OSR (0.6% vs. 3.7%; p < .001). Acute post-operative renal and respiratory insufficiencies were also related to the occurrence of CI (p < .001). CI was associated with greater in hospital mortality (42.2% vs. 2.7% for iAAA, 64.2% vs. 36.3% for rAAA; p < .001) and lower long-term survival for iAAA (Kaplan-Meier analysis). In multivariable analyses, rAAA (odds ratio [OR] 5.59), and higher van Walraven comorbidity score (OR 1.09) were independently associated with greater risk of CI occurrence. EVAR use (OR 0.30) was protective. EVAR use remained protective in stratified analyses within iAAA (OR 0.32) and rAAA (OR 0.26).
CONCLUSION: Post-operative CI after AAA repair is not common but is associated with worse in hospital outcomes and lower long-term survival. EVAR was protective after both rAAA and iAAA repairs. When discussing the treatment of AAA with patients the protective effect of EVAR should be considered. Future studies should validate predictive scores and advance preventive strategies.
Copyright © 2018 European Society for Vascular Surgery. All rights reserved.

Entities:  

Keywords:  Abdominal aortic aneurysm; Colonic ischaemia; Endovascular procedures; Health services research; Ischaemic colitis; Outcome and process assessment (health care)

Mesh:

Year:  2018        PMID: 30037737     DOI: 10.1016/j.ejvs.2018.06.010

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  4 in total

1.  [Colonic ischemia after open and endovascular aortic surgery : Epidemiology, Risk Factors, Diagnosis And Therapy].

Authors:  Dmitriy I Dovzhanskiy; Maani Hakimi; Moritz S Bischoff; Caro la M Wieker; Thilo Hackert; Dittmar Böckler
Journal:  Chirurg       Date:  2020-02       Impact factor: 0.955

Review 2.  Emphasis on Early Identification of Risk Factors to Curtail High Mortality Involved With Ischemic Colitis (IC) After Abdominal Aortic Aneurysm (AAA) Repair.

Authors:  Shashwat Shrivastava; Shitij Shrivastava; Supraja Naidu Avula; Vishwanath Thondamala; Chibuzor V Onuchukwu; Lubna Mohammed
Journal:  Cureus       Date:  2022-03-25

3.  Pelvic radiation therapy as a potential risk factor for ischemic colitis complicating abdominal aortic reconstruction.

Authors:  África Duque Santos; Andrés Reyes Valdivia; Margarita Martín; Julia Ocaña Guaita; Claudio Gandarias Zúñiga
Journal:  J Vasc Surg Cases Innov Tech       Date:  2020-06-25

4.  Predictors of mortality following emergency open colectomy for ischemic colitis: a single-center experience.

Authors:  Nassiba Beghdadi; Elisa Reitano; Frederic Cochennec; Pascal Desgranges; Aurelien Amiot; Iradj Sobhani; Nicolas Mongardon; Olivier Langeron; Margherita Notarnicola; Sébastien Mulé; Alain Luciani; Florence Canoui-Poitrine; Alexis Laurent; Daniele Sommacale; Francesco Brunetti; Nicola De' Angelis
Journal:  World J Emerg Surg       Date:  2020-06-29       Impact factor: 5.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.